Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent Awards 2012 Russell Varian Prize to Two Scientists

Published: Thursday, October 18, 2012
Last Updated: Wednesday, October 17, 2012
Bookmark and Share
Russell Varian prize awarded to Ray Freeman and Weston A. Anderson for innovation in nuclear magnetic resonance.

Agilent Technologies Inc. has announced that it has awarded the 2012 Russell Varian Prize for Innovation in Nuclear Magnetic Resonance to two scientists for their seminal paper, "Use of Weak Perturbing Radio-Frequency Fields in Nuclear Magnetic Double Resonance," published in 1962 in the Journal of Chemical Physics.

The two scientists, Dr. Ray Freeman and Dr. Weston A. Anderson, collaborated on research that has generated important advancements in NMR throughout the past 50 years.

"It is our privilege to pay tribute to these early innovators in NMR technology," said Regina Schuck, Ph.D., general manager of Agilent's Research Products Division.

Schuck continued. "Their invaluable work has provided an easily applicable approach to the unraveling of complex NMR spectra and molecular structure, and has been the catalyst for many notable developments, including a cornerstone of today's techniques, two-dimensional NMR."

Freeman and Anderson initiated their collaboration on NMR in the early 1960s, following Freeman's acceptance of a post-doctoral position at Varian, where Anderson was working as a principal scientist. Now retired, the two men live in the UK and U.S., respectively.

Freeman recalled, "I left the United Kingdom to join Varian primarily because I wanted to work with Wes Anderson-I wanted to be the sorcerer's apprentice-but also because Varian enjoyed a tremendous reputation for original research. A few days after my arrival, I delivered an informal presentation about my work in England and showed a slide of some double-resonance spectra. The epiphany came following a casual remark from a colleague who noted that that one particular trace 'seemed to show a tickling effect.' It was that observation that inspired our future experiments together."

"For the most part, I did the theoretical analysis and Ray Freeman did the experiments," added Anderson. "Prior to meeting at Varian, Dr. Freeman and I had both independently conducted double-resonance experiments, so it was natural for us to collaborate on additional studies in this area. Together, we discovered that by irradiating a single line of the spectrum by a weak RF field, all lines with energy levels in common with the irradiated line would be split into doublet. This procedure ultimately aided in the analysis of complex spectra."

The Russell Varian prize honors the memory of the pioneer behind the first commercial nuclear magnetic resonance spectrometers and cofounder of Varian Associates, which is now part of Agilent Technologies.

The prize is awarded to researchers based on a single innovative contribution (a single paper, patent, lecture, or piece of hardware) that has demonstrated a broad impact on the state of the art in NMR and original contributions that have triggered important advancements in scientific technology.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent, Singapore Institute Collaborate
Agilent Technologies and Singapore's Bioprocessing Technology Institute today announced a collaboration to develop new analytical approaches to specific protein-linked sugar compounds.
Wednesday, July 15, 2015
Agilent Collaborate with A*STAR’s Bioprocessing Technology Institute
Collaboration addresses a critical need in the biopharmaceutical industry.
Tuesday, July 14, 2015
Agilent Technologies and Waters Corporation Formalize Instrument Control Exchange
Agilent Technologies Inc. and Waters Corp have announced a formal agreement to exchange instrument controls to improve the productivity of customers who own software and instruments from both companies.
Wednesday, July 01, 2015
Agilent Technologies Launches New Products for Analyzing Biotherapeutics
Expanded AdvanceBio portfolio enables scientists to speed research and lower costs.
Thursday, June 25, 2015
Agilent to Focus on "Powerful Partnerships, Inspiring Results" at ASMS 2015
Company to introduce solutions enabling new standards in mass spectrometry, lab productivity.
Friday, May 29, 2015
Agilent Announces New CEO Mike McMullen
McMullen elected as chief executive officer by Company’s board of directors.
Thursday, March 19, 2015
Agilent’s Microarray Scanner Approved for In Vitro Diagnostics in China
Regulators approve SureScan Dx as medical device.
Wednesday, January 28, 2015
Utilizing Fast HPLC Screening Methods for the Detection of Steroids
Analysis of steroids improved by choosing the optimal HPLC column for the separation.
Saturday, January 17, 2015
Agilent Names Alacris Theranostics as Certified Provider of Target Enrichment Services
Customers receive consistent data quality, reproducibility and reliability.
Saturday, January 17, 2015
Benefits of SPE for the Analysis of Mycotoxins
Fast and cost-effective sample preparation is essential for the analysis of mycotoxins in food and feed.
Wednesday, January 14, 2015
Dako, Cell Signalling Tech Partner with Companion Diagnostics
Partnership for development of high-quality, cutting-edge companion diagnostic products for diagnosis and treatment of cancer.
Monday, January 12, 2015
Agilent Technologies - Making Better GC Connections
Improving GC connections for reliable, robust and reproducible results.
Wednesday, December 24, 2014
How to Achieve High-Speed, High-Resolution Glycan Mapping for mAb Characterization
The full characterization of biotherapeutics is required by regulatory authorities as properties such as safety, efficacy and the serum half-life of therapeutic proteins can be affected by differences in their glycosylation pattern.
Monday, December 22, 2014
Agilent, Baylor Open Mass Spec Center of Excellence
The new facility aims to boost metabolomics research at Baylor College of Medicine.
Friday, December 05, 2014
Agilent, MRM Proteomics Extend Agreement
Agreement expands on an existing collaboration established in 2012, allowing both organizations to bolster their combined proteomics solutions, comprising reagent kits, hardware and software.
Friday, July 25, 2014
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!